This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sector Snap: Diagnostic Lab Operators Downgraded

NEW YORK (AP) â¿¿ A Raymond James analyst downgraded shares of two diagnostic laboratory operators to "Underperform" Wednesday, saying he believes their profit growth will be slow.

Analyst Alexander Draper downgraded shares of Quest Diagnostics Inc. and Laboratory Corp. of America Holdings. He said the stocks will experience pressure from concerns about cuts to government reimbursement rates and from investor concerns about weak job data. Both companies perform drug testing for employers, and high unemployment hurts that business.

He added that the companies are struggling to create growth in their businesses and are increasingly turning to acquisitions, which creates more risk.

"We believe that persistent lackluster volume growth and existing and upcoming pricing headwinds in both Medicare and commercial will limit earnings growth over the intermediate term," he wrote.

Draper previously rated LabCorp stock at "Outperform," two notches above the "Underperform" rating. He also removed his price target of $95 per share. He had a "Market Perform" rating on Quest shares.

In afternoon trading, LabCorp shares rose 68 cents to $85.24 and Quest stock fell 37 cents to $54.30 while the broader markets rallied.
Copyright 2011 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.10 -1.20%
FB $118.49 0.58%
GOOG $705.13 0.53%
TSLA $212.47 0.44%
YHOO $36.79 -0.41%


Chart of I:DJI
DOW 17,637.29 -23.42 -0.13%
S&P 500 2,046.02 -4.61 -0.22%
NASDAQ 4,697.1260 -19.9680 -0.42%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs